# Vera Therapeutics, Inc. — Form D

Vera Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-25. The offering totals $70.7M, of which $70.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-02-25
- Form: D
- Accession: 0001739074-21-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $70.7M
- Amount sold: $70.7M
- Investors: 23
- Date of first sale: 2020-10-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-390559

## Issuer

- Name: Vera Therapeutics, Inc.
- CIK: 0001831828
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 170 HARBOR WAY, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650-770-0077

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Andrew Cheng | Director | South San Francisco, CA |
| Patrick Enright | Director | Menlo Park, CA |
| Marshall Fordyce | Director | South San Francisco, CA |
| Maha Katabi | Director | San Francisco, CA |
| SCOTT MORRISON | Director | POULSBO, WA |
| Beth Seidenberg | Director | South San Francisco, CA |
| Kurt von Emster | Director | Redwood City, CA |
| Marshall Fordyce | Executive Officer | South San Francisco, CA |

## More

- [CIK 1831828 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1831828&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001739074-21-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.